News

Our presentation at the GTC Boston Protein Discovery Summit

Ossianix had a presentation “High-efficiency brain delivery of rituximab by fusion to an anti-TfR1 VNAR for MS and CNS lymphoma” at the GTC Boston Protein Discovery Summit 2016.

You can download the abstract here.

Comments are closed